TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer

Published:2008-11-11 Issue:11 Volume:99 Page:1849-1858
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Knight J F,Shepherd C J,Rizzo S,Brewer D,Jhavar S,Dodson A R,Cooper C S,Eeles R,Falconer A,Kovacs G,Garrett M D,Norman A R,Shipley J,Hudson D L

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6604774.pdf

Reference56 articles.

1. Alam TN, O'Hare MJ, Laczko I, Freeman A, Al-Beidh F, Masters JR, Hudson DL (2004) Differential expression of CD44 during human prostate epithelial cell differentiation. J Histochem Cytochem 52: 1083–1090

2. Attard G, Clark J, Ambroisine L, Fisher G, Kovacs G, Flohr P, Berney D, Foster CS, Fletcher A, Gerald WL, Moller H, Reuter V, De Bono JS, Scardino P, Cuzick J, Cooper CS (2008) Duplication of the fusion of TMPRSS2 to ERG secquences identifies fatal human prostate cancer. Oncogene 27: 253–263

3. Bandura JL, Edgar BA (2008) Yorkie and Scalloped: partners in growth activation. Dev Cell 14: 315–316

4. Bello-DeOcampo D, Kleinman HK, Deocampo ND, Webber MM (2001) Laminin-1 and alpha6beta1 integrin regulate acinar morphogenesis of normal and malignant human prostate epithelial cells. Prostate 46: 142–153

5. Bonkhoff H, Remberger K (1996) Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 28: 98–106

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategies;Frontiers in Pharmacology;2024-07-26

2. Dampened Regulatory Circuitry of TEAD1/ITGA1/ITGA2 Promotes TGFβ1 Signaling to Orchestrate Prostate Cancer Progression;Advanced Science;2024-01-02

3. Single-cell transcription mapping of murine and human mammary organoids responses to female hormones;2023-09-29

4. TEAD1 regulates ITGA1 and ITGA2 to control prostate cancer progression;2023-04-12

5. Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities;Gut;2022-07-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3